- Baird Medical (BDMD, Financial) hosts UCLA expert to demonstrate advanced microwave ablation (MWA) technology in China.
- The clinical visit emphasizes minimally invasive thyroid treatments at Sun Yat-sen University Cancer Center.
- Collaboration with global medical leaders continues as the company expands its international footprint.
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a leader in medical technology, recently organized a noteworthy clinical visit in Guangzhou, China, featuring Dr. Gary G. Tse, an esteemed interventional radiologist from UCLA Health. This event was designed to highlight Baird Medical's sophisticated microwave ablation (MWA) technology, pivotal for minimally invasive thyroid treatments.
The visit was hosted at the renowned Sun Yat-sen University Cancer Center, where Dr. Tse observed multiple procedures for the ablation of thyroid nodules using Baird Medical's cutting-edge MWA system. This clinical observation provided Dr. Tse with key insights into the precision and efficacy of the technology.
In addition to clinical demonstrations, Dr. Tse and Dr. Michael Mingzhao Xing from Johns Hopkins University School of Medicine engaged in robust academic discussions. These discussions focused on the advancements in managing thyroid nodules, highlighting the continuous evolution in this field.
This initiative underscores Baird Medical's commitment to fostering global partnerships with leading medical experts and institutions. It signals the company's ongoing dedication to expanding the accessibility and effectiveness of minimally invasive treatments worldwide.
